The trading volume of DGX has been increasing recently. Will its stock price rise?

The trading volume of Quest Diagnostics (DGX) has indeed seen an increase over the recent two weeks, with 8.93 million shares traded. However, this does not necessarily indicate that the stock price will rise.

1. **Current Analyst Rating is Neutral**: The average of current price targets set by analysts for DGX is $189.83, with a consensus rating of "Neutral". This suggests that analysts do not see any immediate catalyst for a significant increase in the stock price.

2. **Market Dynamics**: While increased trading volume can sometimes precede a price movement, it is not a guarantee of a rise. The stock price is influenced by a multitude of factors including market sentiment, company performance, and industry trends. Without positive news or strong earnings reports to support a price increase, the trading volume alone may not lead to a rise in the stock price.
3. **Financial Health**: It's important to consider DGX's financial health. If the company is performing well with strong fundamentals, a higher trading volume could reflect investor interest or a reaction to recent news. However, without specific information on the company's financials, it's challenging to make a definitive prediction.

In conclusion, while the increased trading volume of DGX is a notable point, it is not a definitive indicator of a stock price rise. The neutral analyst consensus and the absence of specific positive factors suggest caution for investors looking to predict short-term price movements.